{"id":963,"date":"2021-02-16T10:11:00","date_gmt":"2021-02-16T09:11:00","guid":{"rendered":"https:\/\/ago-ovar.de\/imprint\/"},"modified":"2024-07-22T12:38:27","modified_gmt":"2024-07-22T10:38:27","slug":"legal-notice","status":"publish","type":"page","link":"https:\/\/ago-ovar.de\/en\/legal-notice\/","title":{"rendered":"Legal Notice"},"content":{"rendered":"

[et_pb_section fb_built=”1″ _builder_version=”4.16″ background_color=”#144c82″ use_background_color_gradient=”on” background_color_gradient_stops=”#144c82 0%|#003466 100%” background_color_gradient_start=”#144c82″ background_color_gradient_end=”#003466″ custom_margin=”||||false|true” custom_padding=”32px|10%|32px|10%|false|true” saved_tabs=”all” global_colors_info=”{}”][et_pb_row _builder_version=”4.16″ global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ global_colors_info=”{}”][et_pb_text _builder_version=”4.16″ text_text_color=”#ffffff” text_font_size=”22px” text_line_height=”1.8em” text_orientation=”center” global_colors_info=”{}”]<\/p>\n

The group\u2019s initial objective was to enhance the therapy of ovarian carcinoma. The AGO Study Group has been established in 1993 as a non-profit organisation under the original name \u2018AGO Studiengruppe Ovarialkarzinom (AGO-OVAR)\u2019.<\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ specialty=”on” _builder_version=”4.16″ background_color=”#e0edf9″ global_colors_info=”{}”][et_pb_column type=”3_4″ specialty_columns=”3″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_row_inner _builder_version=”4.16″ custom_padding=”||13px|||” global_colors_info=”{}”][et_pb_column_inner saved_specialty_column_type=”3_4″ _builder_version=”4.16″ global_colors_info=”{}”][et_pb_text _builder_version=”4.16″ text_text_color=”#000000″ header_font=”|700||on|||||” header_text_color=”#11487E” header_2_text_color=”#11487E” custom_margin=”||21px|||” global_colors_info=”{}”]<\/p>\n

Imprint<\/h1>\n

[\/et_pb_text][\/et_pb_column_inner][\/et_pb_row_inner][et_pb_row_inner _builder_version=”4.16″ global_colors_info=”{}”][et_pb_column_inner saved_specialty_column_type=”3_4″ _builder_version=”4.16″ global_colors_info=”{}”][et_pb_text _builder_version=”4.27.0″ text_text_color=”#000000″ text_font_size=”16px” header_text_color=”#11487E” header_2_text_color=”#11487E” header_2_font_size=”24px” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″]<\/p>\n

AGO Research GmbH
Kaiser-Friedrich-Ring 71
65185 Wiesbaden
Deutschland<\/p>\n

Vertreten durch:
<\/strong>Managing Director: Stefanie Barth
Registered Seat: Kaiser-Friedrich-Ring 71, 65185 Wiesbaden<\/p>\n

Kontakt:
Fon<\/strong>: +49 611 880467-0
Fax: +49 611 880467-67
E-Mail: webmaster@ago-ovar.de<\/a><\/p>\n

Registereintrag:
<\/strong>County Court Wiesbaden HRB 24129<\/p>\n

Umsatzsteuer-ID:
<\/strong>UVAT identification number DE 264466146<\/p>\n

 <\/p>\n

[\/et_pb_text][et_pb_text _builder_version=”4.27.0″ text_text_color=”#000000″ text_font_size=”16px” header_text_color=”#11487E” header_2_text_color=”#11487E” header_2_font_size=”24px” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″]<\/p>\n

 <\/p>\n

Copyright information<\/strong><\/p>\n

Layout, texts, images and graphics on this page are protected by law. This applies in particular to brand and patent rights, but also to all other forms of intellectual property rights. Reproduction and \/ or distribution of individual contents of these pages in whole or in part and \/ or of complete pages are strictly forbidden. Any violation will be prosecuted to the fullest extent of the civil and \/ or criminal law.<\/p>\n

[\/et_pb_text][\/et_pb_column_inner][\/et_pb_row_inner][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_sidebar area=”et_pb_widget_area_5″ show_border=”off” admin_label=”Seitenleiste” _builder_version=”4.16″ header_text_color=”#000000″ body_font=”|700|||||||” body_text_color=”#ef5b21″ background_color=”rgba(255,255,255,0.6)” background_enable_color=”off” min_height=”257px” custom_padding=”8%|4%|4%|8%|false|false” saved_tabs=”all” global_colors_info=”{}”][\/et_pb_sidebar][\/et_pb_column][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"

The group\u2019s initial objective was to enhance the therapy of ovarian carcinoma. The AGO Study Group has been established in 1993 as a non-profit organisation under the original name \u2018AGO Studiengruppe Ovarialkarzinom (AGO-OVAR)\u2019.ImprintAGO Research GmbHKaiser-Friedrich-Ring 7165185 WiesbadenDeutschland Vertreten durch:Managing Director: Stefanie BarthRegistered Seat: Kaiser-Friedrich-Ring 71, 65185 Wiesbaden Kontakt:Fon: +49 611 880467-0Fax: +49 611 880467-67E-Mail: webmaster@ago-ovar.de […]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":100,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"class_list":["post-963","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/ago-ovar.de\/en\/wp-json\/wp\/v2\/pages\/963","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ago-ovar.de\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/ago-ovar.de\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/ago-ovar.de\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/ago-ovar.de\/en\/wp-json\/wp\/v2\/comments?post=963"}],"version-history":[{"count":14,"href":"https:\/\/ago-ovar.de\/en\/wp-json\/wp\/v2\/pages\/963\/revisions"}],"predecessor-version":[{"id":2026,"href":"https:\/\/ago-ovar.de\/en\/wp-json\/wp\/v2\/pages\/963\/revisions\/2026"}],"wp:attachment":[{"href":"https:\/\/ago-ovar.de\/en\/wp-json\/wp\/v2\/media?parent=963"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}